Stay updated with breaking news from Patrick John Finn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its target price lifted by investment analysts at Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price would indicate a potential upside of 7.43% from the company’s current price. […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.84) by $0.05, Briefing.com reports. The firm had revenue of $75.30 million for the quarter, compared to analysts’ expectations of $70.70 million. Twist Bioscience had a negative return […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total value of $65,480.88. Following the sale, the chief operating officer now owns 176,206 shares […]
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total transaction of $65,480.88. Following the completion of the sale, the chief operating officer now directly owns […]